Status:

COMPLETED

Study to Evaluate the Inflammatory Cells Activity in Patients With Persistent Asthma Treated With Montelukast (0476-403)(COMPLETED)

Lead Sponsor:

University of Brasilia

Conditions:

Asthma

Eligibility:

All Genders

2-18 years

Phase:

PHASE4

Brief Summary

Verify if the quantitative parameters of the eosinophils activation and phagocyte system function show a predictive value for clinical response and prognostic in patients with persistent asthma treate...

Eligibility Criteria

Inclusion

  • Patients Between 2-18 Years With Persistent Asthma

Exclusion

  • Patients \> 18 Years Old And \< 2 Years Old

Key Trial Info

Start Date :

September 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2009

Estimated Enrollment :

83 Patients enrolled

Trial Details

Trial ID

NCT00770900

Start Date

September 1 2008

End Date

December 1 2009

Last Update

December 20 2010

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.